Event Description
Vaccines have long been supported by a rigorous review and recommendation process, though ongoing federal changes have raised new questions about how vaccine policy and routine recommendations may evolve. Join this webinar to learn how vaccines are licensed, how recommendations have developed in the U.S., and how to confidently address common questions about routine immunizations.
About the Speaker
Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado, a pediatric infectious diseases specialist, an investigator at ACCORDS (Adult and Child Center for Outcomes Research and Delivery Science), and the Director of the Colorado Children’s Outcomes Network (COCONet), Colorado’s pediatric practice-based research network. With over 240 peer-reviewed publications, Dr. O’Leary’s primary area of research focuses on prevention of vaccine-preventable diseases through understanding clinical, attitudinal and infrastructural barriers to vaccination, and developing and testing interventions to address those barriers. Much of his recent work focuses on studying how best to communicate about vaccines in clinical settings. Dr. O’Leary is a member of the American Academy of Pediatrics (AAP) Council on School Health and serves as the Chair of the Committee on Infectious Diseases (the Red Book Committee) for the AAP. Dr. O’Leary served for many years as a liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP) for the AAP and Pediatric Infectious Diseases Society, and until recent events served on several ACIP Work Groups, including COVID-19, RSV and HPV. He also serves as the co-chair of the Policy Committee for Immunize Colorado, as a Director for the National Foundation for Infectious Diseases, and as a member of the Steering Committee for Voices for Vaccines. Prior to his infectious diseases fellowship, Dr. O’Leary was a partner in a large general pediatric practice in Fort Collins, Colorado for 8 years.
Continuing Education
Instructions for claiming continuing education credit are provided during the webinar.
For questions regarding continuing education, please email cire.cme@ndsu.edu.
Continuing Medical Education (CME)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and NDSU. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education (CPE)
This activity is approved for 0.1 CEU of pharmacist and pharmacy technician credit by CEImpact. CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
More information is available via the NDSU CAP Center.
